Decision

UK REACH authorisation for MeiraGTx UK II Limited, 11 November 2022

Decision on application for authorisation under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 21 November 2022

Documents

UK REACH authorisation for MeiraGTx UK II Limited, 11 November 2022

PDF, 120 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).

Authorised use

Industrial use of 4-tert-OPnEO as non-ionic surfactant, employed in the purification of antigens in in vitro diagnostics tests for infectious diseases, auto-immunity markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology.

Holder of the authorisation and authorisation number

MeiraGTx UK II Limited (UKREACH/22/04/0).

Date of decision

11 November 2022

Published 21 November 2022